VERACYTE, INC. — Director's Dealing 2019

Aug 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2019-08-12

Reporting Person: Kennedy Giulia C (Chief Scientific & Med Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-12	Common Stock	M	8243	$10.45	Acquired	56575	Direct
2019-08-12	Common Stock	M	1667	$8.86	Acquired	58242	Direct
2019-08-12	Common Stock	M	5000	$6.45	Acquired	63242	Direct
2019-08-12	Common Stock	M	1563	$5.43	Acquired	64805	Direct
2019-08-12	Common Stock	M	7083	$9.05	Acquired	71888	Direct
2019-08-12	Common Stock	M	4406	$5.98	Acquired	76294	Direct
2019-08-12	Common Stock	S	28257	$25.3776	Disposed	48037	Direct
2019-08-13	Common Stock	M	4640	$10.45	Acquired	52677	Direct
2019-08-13	Common Stock	S	4640	$25.45	Disposed	48037	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-12	Stock Option (right to buy)	$10.45	M	8243	Disposed	2024-09-15	Common Stock (8243.0)	Direct
2019-08-12	Stock Option (right to buy)	$8.86	M	1667	Disposed	2025-03-01	Common Stock (1667.0)	Direct
2019-08-12	Stock Option (right to buy)	$6.45	M	5000	Disposed	2026-02-28	Common Stock (5000.0)	Direct
2019-08-12	Stock Option (right to buy)	$5.43	M	1563	Disposed	2026-03-14	Common Stock (1563.0)	Direct
2019-08-12	Stock Option (right to buy)	$9.05	M	7083	Disposed	2027-03-02	Common Stock (7083.0)	Direct
2019-08-12	Stock Option (right to buy)	$5.98	M	4406	Disposed	2028-03-01	Common Stock (4406.0)	Direct
2019-08-13	Stock Option (right to buy)	$10.45	M	4640	Disposed	2024-09-15	Common Stock (4640.0)	Direct

Footnotes

F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 3, 2019.

F2: Represents weighted average sales price. Sale prices for the transactions range from $25.12 to $25.94. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

F3: The option is fully vested.

F4: The option became exercisable as to 25% of the shares on March 1, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

F5: The option became exercisable as to 25% of the shares on March 15, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

F6: The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.

F7: The option became exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.